About Prostate Cancer
Prostate cancer is the most commonly diagnosed non-cutaneous cancer in American men. There are nearly 3 million prostate cancer survivors in the U.S. today. All men are at risk, some more than others. This is a cancer that has very few, if any, noticeable symptoms when it is in its earliest, curable stage.
The prostate is a small, walnut-shaped gland located below the bladder and in front of the rectum. It is part of the male reproductive system and necessary for reproduction. The prostate surrounds the upper part of the urethra, which is the tube that carries urine from the bladder.
Prostate cancer begins in the prostate and, if left untreated, may spread to other parts of the body. When found while it is still in the prostate, it can be effectively treated, offering the best chance for cure.
Countless men can be helped by talking about the disease, increasing awareness and helping them get treatment and support.
This year there will be 161,360 new cases of prostate cancer and 26, 730 deaths from prostate cancer.
Risk Factors and Treatment
Risk factors include:
- Increasing age
- African-American ancestry
- Family history
- Certain inherited genetic conditions (BRCA and Lynch)
There is a lot of discussion about screening and testing. Start talking to your doctor at 45 about regular prostate-specific antigen (PSA) testing depending upon your risk factors.
There are many treatment options available for men who have been diagnosed with prostate cancer.
Treatment depends on many factors; there is no one size fits all “right” answer. If diagnosed, a man needs to learn about his options, get information and make an informed decision.
Factors to know about your diagnosis as you decide on treatment include:
- Gleason score
- Clinical stage
Our beneficiaries — Prostate Health Education Network (PHEN), Us Too and ZERO — provide support, education and resources to the prostate cancer community. We encourage you to visit their sites and learn more about what they have to offer. Their services and programs are free and we fully support their missions and good work.